Menu
GeneBe

NRXN1

neurexin 1, the group of Neurexins|MicroRNA protein coding host genes

Basic information

Region (hg38): 2:49918502-51225575

Links

ENSG00000179915NCBI:9378OMIM:600565HGNC:8008Uniprot:P58400, Q9ULB1AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • schizophrenia (Limited), mode of inheritance: Unknown
  • autism (Moderate), mode of inheritance: AD
  • Pitt-Hopkins-like syndrome 2 (Moderate), mode of inheritance: AR
  • chromosome 2p16.3 deletion syndrome (Strong), mode of inheritance: AD
  • Pitt-Hopkins-like syndrome 2 (Strong), mode of inheritance: AR
  • complex neurodevelopmental disorder (Definitive), mode of inheritance: AD

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Schizophrenia 17; Pitt-Hopkins-like syndrome 2AD/ARGeneralGenetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testingCraniofacial; Neurologic18369103; 17989066; 18945720; 19896112; 21424692

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the NRXN1 gene.

  • Pitt-Hopkins-like syndrome 2 (25 variants)
  • not provided (4 variants)
  • Autism spectrum disorder (2 variants)
  • Intellectual disability (1 variants)
  • Inborn genetic diseases (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the NRXN1 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
21
clinvar
421
clinvar
6
clinvar
448
missense
884
clinvar
5
clinvar
2
clinvar
891
nonsense
10
clinvar
7
clinvar
3
clinvar
20
start loss
3
clinvar
3
frameshift
18
clinvar
7
clinvar
5
clinvar
30
inframe indel
10
clinvar
8
clinvar
1
clinvar
19
splice donor/acceptor (+/-2bp)
2
clinvar
9
clinvar
2
clinvar
13
splice region
34
51
85
non coding
1
clinvar
1
clinvar
96
clinvar
206
clinvar
107
clinvar
411
Total 31 24 1024 640 116

Highest pathogenic variant AF is 0.00000658

Variants in NRXN1

This is a list of pathogenic ClinVar variants found in the NRXN1 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
2-49918552-A-ATTGTC Pitt-Hopkins-like syndrome Uncertain significance (Jun 14, 2016)336495
2-49918598-A-T Pitt-Hopkins-like syndrome 2 Uncertain significance (Jan 12, 2018)336496
2-49918666-A-C Pitt-Hopkins-like syndrome 2 Uncertain significance (Jan 13, 2018)336497
2-49918740-G-A Pitt-Hopkins-like syndrome 2 Uncertain significance (Jan 12, 2018)898969
2-49918758-T-G Pitt-Hopkins-like syndrome 2 Uncertain significance (Jan 13, 2018)898970
2-49918821-G-A Pitt-Hopkins-like syndrome 2 Uncertain significance (Jan 13, 2018)336498
2-49919066-C-T Pitt-Hopkins-like syndrome 2 Benign (Jan 13, 2018)898971
2-49919109-A-G Pitt-Hopkins-like syndrome 2 Uncertain significance (Jan 12, 2018)336499
2-49919157-T-C Pitt-Hopkins-like syndrome 2 Uncertain significance (Jan 12, 2018)894841
2-49919178-T-C Pitt-Hopkins-like syndrome 2 Uncertain significance (Jan 13, 2018)336500
2-49919199-C-G Pitt-Hopkins-like syndrome 2 Uncertain significance (Jan 13, 2018)894842
2-49919268-T-TCTAA Pitt-Hopkins-like syndrome Uncertain significance (Jun 14, 2016)336501
2-49919315-T-G Pitt-Hopkins-like syndrome 2 Uncertain significance (Jan 13, 2018)336502
2-49919409-G-A Pitt-Hopkins-like syndrome 2 Uncertain significance (Jan 13, 2018)336503
2-49919430-T-C Pitt-Hopkins-like syndrome 2 Uncertain significance (Jan 13, 2018)336504
2-49919433-C-G Pitt-Hopkins-like syndrome 2 Benign (Jan 13, 2018)336505
2-49919554-A-AATC Pitt-Hopkins-like syndrome Uncertain significance (Jun 14, 2016)336506
2-49919558-T-C Pitt-Hopkins-like syndrome 2 Uncertain significance (Jan 13, 2018)896279
2-49919559-TA-T Pitt-Hopkins-like syndrome Uncertain significance (Jun 14, 2016)336508
2-49919559-T-TA Pitt-Hopkins-like syndrome Uncertain significance (Jun 14, 2016)336507
2-49919567-A-G Pitt-Hopkins-like syndrome 2 Uncertain significance (Jan 12, 2018)336509
2-49919571-C-T Pitt-Hopkins-like syndrome 2 Uncertain significance (Jan 12, 2018)336510
2-49919572-C-T Pitt-Hopkins-like syndrome 2 Benign (Jan 13, 2018)336511
2-49919646-G-C Pitt-Hopkins-like syndrome 2 Uncertain significance (Jan 12, 2018)896280
2-49919658-G-T Pitt-Hopkins-like syndrome 2 Uncertain significance (Jan 13, 2018)336512

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
NRXN1protein_codingprotein_codingENST00000404971 231114032
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
1.000.0003611257310171257480.0000676
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense2.566818970.7590.000054110084
Missense in Polyphen212368.050.576014246
Synonymous-3.354513691.220.00002533017
Loss of Function6.441066.80.1500.00000378796

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.00002900.0000290
Ashkenazi Jewish0.000.00
East Asian0.0001780.000163
Finnish0.000.00
European (Non-Finnish)0.00008030.0000703
Middle Eastern0.0001780.000163
South Asian0.0001380.000131
Other0.0001990.000163

dbNSFP

Source: dbNSFP

Function
FUNCTION: Neuronal cell surface protein that may be involved in cell recognition and cell adhesion by forming intracellular junctions through binding to neuroligins. May play a role in formation or maintenance of synaptic junctions. May mediate intracellular signaling. May play a role in angiogenesis (By similarity). {ECO:0000250}.;
Pathway
Cell adhesion molecules (CAMs) - Homo sapiens (human);Extracellular matrix organization;Neuronal System;Neurexins and neuroligins;Non-integrin membrane-ECM interactions;Protein-protein interactions at synapses (Consensus)

Intolerance Scores

loftool
0.297
rvis_EVS
-1.79
rvis_percentile_EVS
2.25

Haploinsufficiency Scores

pHI
0.0902
hipred
Y
hipred_score
0.707
ghis
0.646

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.909

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Nrxn1
Phenotype
endocrine/exocrine gland phenotype; growth/size/body region phenotype; homeostasis/metabolism phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); limbs/digits/tail phenotype; digestive/alimentary phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); normal phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); skeleton phenotype; immune system phenotype;

Zebrafish Information Network

Gene name
nrxn1a
Affected structure
caudal vein plexus
Phenotype tag
abnormal
Phenotype quality
malformed

Gene ontology

Biological process
neuron cell-cell adhesion;chemical synaptic transmission;neurotransmitter secretion;axon guidance;synapse assembly;learning;adult behavior;social behavior;vocal learning;neuromuscular process controlling balance;positive regulation of synapse assembly;positive regulation of synaptic transmission, glutamatergic;prepulse inhibition;vocalization behavior;positive regulation of synapse maturation;postsynaptic membrane assembly;gephyrin clustering involved in postsynaptic density assembly;neuroligin clustering involved in postsynaptic membrane assembly;postsynaptic density protein 95 clustering;regulation of synaptic vesicle cycle;regulation of postsynaptic density assembly;trans-synaptic signaling by endocannabinoid;synaptic membrane adhesion;regulation of presynapse assembly;positive regulation of excitatory postsynaptic potential;regulation of grooming behavior
Cellular component
nucleolus;endoplasmic reticulum;plasma membrane;integral component of plasma membrane;cell surface;cell junction;nuclear membrane;vesicle;protein-containing complex;presynaptic membrane;neuronal cell body;Schaffer collateral - CA1 synapse;glutamatergic synapse;GABA-ergic synapse;integral component of presynaptic active zone membrane
Molecular function
calcium channel regulator activity;calcium ion binding;protein binding;acetylcholine receptor binding;signaling receptor activity;cell adhesion molecule binding;neuroligin family protein binding